Aragen Life Sciences is a global biopharmaceutical research and manufacturing partner offering CRDMO services that span discovery through commercialization. The company focuses on small molecules and large molecules (biologics) with integrated drug discovery, development, and manufacturing capabilities. With R&D campuses in the US and India and a global footprint, Aragen serves 4000+ scientists and 3000+ projects monthly for a wide range of biotech and pharmaceutical clients. Headquartered in India, the firm emphasizes quality, EHS, and a customer-centric approach to accelerate drug programs.
No recent deals for this company.